Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taliderm and VAC for Pressure Ulcers
NCT02237287Phase 1Terminated
- Sponsor
- University Hospital Basel
- Start
- Feb 2011
- Primary completion
- Aug 2012
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (3 arms), sponsored by University Hospital Basel. Primary endpoints: Number of Participants with Adverse Events as a Measure of Safety and Tolerability at 1 year and Wound surface area increase, respectively decrease at 1 year. Started Feb 2011; status: terminated.
Beyond the preview
Go deeper on NCT02237287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237287.